Covington-based CTI Clinical Trial and Consulting Services (CTI), a multi-national, privately held, full-service contract research organization announces U.S. expansion on both the East and West coasts.
The company is expanding their current office footprint in Raleigh, North Carolina, doubling the current space to accommodate immediate and future growth. CTI has also moved their West Coast office in San Francisco to a larger space that is more accessible to biopharma companies, the downtown area, and the airport.
“We’re excited to continue growing across the United States outside of our headquarters in Covington,” remarks Timothy J. Schroeder, Founder and CEO. “The expanded office in Raleigh and the new office in San Francisco will allow us to continue to accommodate our ever expanding workforce and to tap into the rich populations in both cities for new talent.”
CTI, with an annual staff retention rate of 95 percent, has been working for two decades in the drug development industry across North America, Europe, South America, Pac-Asia, and Africa, specializing in clinical research programs involving critically ill patient populations.
It has more than 30 offices worldwide to serve more than 120 pharmaceutical, biotechnology, and medical device clients. The company moved its global corporate headquarters to Northern Kentucky in 2017.
CTI Clinical Trial and Consulting Services is a global, privately held, full-service contract research organization (CRO), delivering a complete spectrum of clinical trial and consulting services throughout the lifecycle of development, from concept to commercialization.
CTI’s focused therapeutic approach provides pharmaceutical, biotechnology, and medical device firms with clinical and disease area expertise in rare diseases, regenerative medicine/gene therapy, immunology, transplantation, nephrology, hematology/oncology, neurology, infectious diseases, hepatology, cardiopulmonary, and pediatric populations.
CTI also offers a fully integrated multi-specialty clinical research site that conducts phase I-IV trials. CTI has a passion for helping life-changing therapies succeed in chronically and critically ill patient populations.
With clinical trial experience across six continents, CTI partners with research sites, patients, and sponsors to fulfill unmet medical needs.
For more information click here.
CTI Clinical Trial and Consulting Services